| Bioactivity | p-SCN-Bn-DOTA(tBu)4 is the derivative of DOTA (HY-W053583). p-SCN-Bn-DOTA(tBu)4 is the component of the Gd(III)-DOTA-IAC, which is a targeted magnetic resonance imaging (MRI) contrast agent for αvβ3 integrin receptor[1]. |
| CAS | 1703752-99-1 |
| Formula | C40H65N5O8S |
| Molar Mass | 776.04 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kim YS, et al., Synthesis and characterization of gadolinium-Peptidomimetic complex as an αvβ3 integrin targeted MR contrast agent. Bioorg Med Chem Lett. 2015;25(10):2056-9. |
p-SCN-Bn-DOTA(tBu)4
CAS: 1703752-99-1 F: C40H65N5O8S W: 776.04
p-SCN-Bn-DOTA(tBu)4 is the derivative of DOTA (HY-W053583). p-SCN-Bn-DOTA(tBu)4 is the component of the Gd(III)-DOTA-IAC
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.